BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34486474)

  • 1. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.
    Ye Y; Yu F; Li Z; Xie Y; Yu X
    Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1.
    Xu L; Wang Z; Yin C; Pan F; Shi T; Tian Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):685-691. PubMed ID: 33168192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing-related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR-199a-5p/SRSF1 axis and impacting Anillin.
    Zhang Y; Lu Y; Wang N; Yang Y; Hao F; Fei X; Chen Y; Wang J
    Mol Carcinog; 2024 Jun; 63(6):1064-1078. PubMed ID: 38411272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.
    Deng G; Luo Y; Zhang Y; Zhang J; He Z
    Bioengineered; 2022 Feb; 13(2):2194-2206. PubMed ID: 35030977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 10. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
    Feng Z; Ke S; Wang C; Lu S; Xu Y; Yu H; Li Z; Yin B; Li X; Hua Y; Qian B; Bai M; Fu Y; Zhang Y; Wu Y; Ma Y
    Oncogene; 2023 Jun; 42(24):2017-2030. PubMed ID: 37142680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
    Sun Y; Lei B; Huang Q
    Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
    Huang D; Cao L; Zheng S
    J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma.
    Hong W; Zhang Y; Wang S; Li Z; Zheng D; Hsu S; Zhou J; Fan J; Chen Z; Xia X; Zeng Z; Gao Q; Yu M; Du S
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308009. PubMed ID: 38381090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
    Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
    Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells.
    Huang X; Xiang L; Wang B; Hu J; Liu C; Ren A; Du K; Ye G; Liang Y; Tang Y; Yang D; Yuan Y
    J Transl Med; 2021 Mar; 19(1):120. PubMed ID: 33757532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.